Casandra
Casandra Test Code QD06063Version 1 (DRAFT)
Performing Lab
Lab Quest DiagnosticsLab Test ID 90477
BRAF Mutation Analysis — Papillary Thyroid Cancer
Also known as: B-RAF
Clinical Use
Order TestUse
Quest’s BRAF Mutation Analysis for papillary thyroid cancer identifies mutations within the BRAF gene—most notably V600E—that are commonly observed in papillary thyroid carcinoma and are associated with poorer prognosis and disease recurrence. The test helps clinicians confirm malignancy and may inform risk stratification and management decisions in patients with suspected or confirmed papillary thyroid carcinoma. It may also aid in therapeutic planning if targeted therapies are considered.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
NGS
Biomarkers
BRAF
GeneSNV/Indel • Mutation • Categorical (e.g., Positive / Negative / Indeterminate)
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Not provided.
Related Tests
Other tests from different labs that may be relevant
BRAF Gene Mutation Analysis
Labcorp
BRAF V600E/V600K Somatic Mutation Analysis, Tumor
Mayo Clinic Lab
BRAF Mutation Analysis by PCR
NeoGenomics
BRAF Gene Mutation Analysis - Melanoma
Labcorp
BRAF V600E
NeoGenomics
BRAF V600E Mutation Detection in Circulating Cell-Free DNA by Digital Droplet PCR
ARUP Laboratories
Cell-Free DNA BRAF V600, Blood
Mayo Clinic Lab
BRAF V600E Immunostain, Technical Component Only
Mayo Clinic Lab
BRAF V600 Mutation Analysis
MPLN
BRAF V600E Immunohistochemistry (IHC)
NeoGenomics